Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Berger

Showing results (31-40 of 320) with videos related to

Pageof 32
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 30, 2003
Promyelocytic HL60 cells express NADPH oxidase and are excellent targets in a rapid spectrophotometric microplate assay for extracellular superoxideOlga Teufelhofer, Rosa-Maria Weiss, Wolfram Parzefall, et al.
Inorganic Chemistry Frontiers|July 13, 2023
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugsAlexander Kastner, Theresa Mendrina, Florian Bachmann, et al.
Cancers|November 26, 2022
Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with PonatinibBahil Ghanim, Dina Baier, Christine Pirker, et al.
Cancer Letters|April 3, 2009
The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cellsTatjana Mijatovic, Ute Jungwirth, Petra Heffeter, et al.
Cells|March 14, 2026
<i>MGMT</i> Promoter and Enhancer Methylation in Melanoma Brain Metastases and Glioblastoma: Shared and Distinct FeaturesKatharina Pühringer, Benno Fehringer, Katja Zappe, et al.
Journal of Polymer Science. Part A, Polymer Chemistry|April 15, 2014
Water-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation BehaviorSandra Wilfert, Aitziber Iturmendi, Wolfgang Schoefberger, et al.
Chemical Reviews|November 30, 2018
Metal Drugs and the Anticancer Immune ResponseBernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Bioorganic Chemistry|April 2, 2020
Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinibBjoern Bielec, Hemma Schueffl, Alessio Terenzi, et al.
Oncology Letters|February 14, 2018
Dynamics of CRISPR/Cas9-mediated genomic editing of the <i>AXL</i> locus in hepatocellular carcinoma cellsIrene Scharf, Lisa Bierbaumer, Heidemarie Huber, et al.
Brain Pathology (Zurich, Switzerland)|October 25, 2008
Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cellsShannon Fortin, Marie Le Mercier, Isabelle Camby, et al.
Pageof 32

Showing results (31-40 of 320) with videos related to

Sort By:
Pageof 32
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 30, 2003
Promyelocytic HL60 cells express NADPH oxidase and are excellent targets in a rapid spectrophotometric microplate assay for extracellular superoxideOlga Teufelhofer, Rosa-Maria Weiss, Wolfram Parzefall, et al.
Inorganic Chemistry Frontiers|July 13, 2023
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugsAlexander Kastner, Theresa Mendrina, Florian Bachmann, et al.
Cancers|November 26, 2022
Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with PonatinibBahil Ghanim, Dina Baier, Christine Pirker, et al.
Cancer Letters|April 3, 2009
The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cellsTatjana Mijatovic, Ute Jungwirth, Petra Heffeter, et al.
Cells|March 14, 2026
<i>MGMT</i> Promoter and Enhancer Methylation in Melanoma Brain Metastases and Glioblastoma: Shared and Distinct FeaturesKatharina Pühringer, Benno Fehringer, Katja Zappe, et al.
Journal of Polymer Science. Part A, Polymer Chemistry|April 15, 2014
Water-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation BehaviorSandra Wilfert, Aitziber Iturmendi, Wolfgang Schoefberger, et al.
Chemical Reviews|November 30, 2018
Metal Drugs and the Anticancer Immune ResponseBernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Bioorganic Chemistry|April 2, 2020
Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinibBjoern Bielec, Hemma Schueffl, Alessio Terenzi, et al.
Oncology Letters|February 14, 2018
Dynamics of CRISPR/Cas9-mediated genomic editing of the <i>AXL</i> locus in hepatocellular carcinoma cellsIrene Scharf, Lisa Bierbaumer, Heidemarie Huber, et al.
Brain Pathology (Zurich, Switzerland)|October 25, 2008
Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cellsShannon Fortin, Marie Le Mercier, Isabelle Camby, et al.
Pageof 32